Eli Lilly & CO.
Intellectual Property, Accident & Injury, Other, Lawsuit & Dispute, Employment
Firm Size:
1
Eli Lilly & CO.
Lawyers
Angela Kay Wade
General Practice,
Anita Marie Hodgson
General Practice,
Arleen Palmberg
General Practice,
Audrey Mills
General Practice,
Brian Paul Barrett
General Practice,
Bronwen L Mantlo
Donald L. Corneglio
General Practice,
Edward Joseph Prein
General Practice,
Elizabeth Teresa Lauch Dusold
General Practice,
Gary Rudolph Rom
General Practice,
George Joseph Berry
General Practice,
James Bernard Lootens
General Practice,
Jennifer C. Lee-Crist
General Practice,
John Charles Demeter
Administrative Law, Licensing, Intellectual Property, Patent, Patent
Joseph Henry Marxer
Environmental Law Other, General Practice,
Lauren Elizabeth Grizzard
Immigration, General Practice,
Lawrence Thomas Welch
Intellectual Property, Patent, General Practice,
Matthew Timothy Lord
Lawsuit & Dispute, Health Care, General Practice,
Melissa Stapleton Barnes
General Practice,
Michael James Harrington
General Practice,
Michael Patrick Bigelow
General Practice,
Paul Robert Cantrell
Intellectual Property, General Practice,
Paul Joseph Gaylo
Intellectual Property, General Practice,
Paul John Koivuniemi
General Practice,
Paula Taylor Whitfield
General Practice,
Randy Dennis Loser
General Practice,
Sandra Jean Sommers
Employment, General Practice,
Susan Kay Kindig
General Practice,
Thomas Gerard Plant
General Practice,
William Bernard Scanlon
General Practice,
Reviews
The medical drug making facility I visited was truly impressive. From the moment I stepped inside, it was evident that this facility was committed to producing high-quality medications while prioritizing safety and compliance.
Good company to work with.
Very impressive. Super clean and great to see ???? how things are made. Keep make the country healthy with the medicine you make ????.
Won't let you in to go to the restroom even if your mate. Require to have your vaccination card. Know how many of us carry that card around?
Company renowned for the mass production of insulin and polio vaccines. It has become notorious on the Internet for the excessively high price of its Humalog vial (100 units), compared to actual production costs (as seen in many othe countries of the World, whose high-end versions of the same product cost 16 times less). Such high price is not just the result of a choice by the company, but also of an interplay of stakeholders, distribution companies, chemistry shops, insurance companies, and poor government choices. It is true that citizens who enjoy an insurance subscription will never pay the full amount out of their pockets. Buy the risk is apparent for those who are enduring hardships: life-saving drugs should never be priced that high because you never know who might need them last minute. Picture is taken from the Internet.